Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Leases (2019 - 2025)

Historic Current Leases for AC Immune (ACIU) over the last 7 years, with Q3 2025 value amounting to $1.3 million.

  • AC Immune's Current Leases rose 6308.31% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 6308.31%. This contributed to the annual value of $1.2 million for FY2024, which is 9984.54% down from last year.
  • According to the latest figures from Q3 2025, AC Immune's Current Leases is $1.3 million, which was up 6308.31% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Current Leases ranged from a high of $757.6 million in Q4 2023 and a low of $568835.9 during Q4 2022
  • In the last 5 years, AC Immune's Current Leases had a median value of $801019.9 in 2024 and averaged $164.7 million.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 13765590.29% in 2021, then tumbled by 9990.8% in 2022.
  • AC Immune's Current Leases (Quarter) stood at $618.2 million in 2021, then tumbled by 99.91% to $568835.9 in 2022, then soared by 133081.15% to $757.6 million in 2023, then plummeted by 99.85% to $1.2 million in 2024, then grew by 11.54% to $1.3 million in 2025.
  • Its Current Leases was $1.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.1 million in Q1 2025.